Panretinal Photocoagulation Versus Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
Phase of Trial: Phase II/III
Latest Information Update: 25 May 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 19 May 2017 Status changed from active, no longer recruiting to completed.
- 13 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 16 Mar 2016 New trial record